
Healthcare today is increasingly shaped by actuarial logic rather than human outcomes. Coverage decisions are driven by algorithms, prior authorizations delay care, and access to innovation is often filtered through spreadsheets designed to manage cost rather than improve lives. Yet despite these barriers, medical innovation—especially pharmaceutical innovation—remains one of the most powerful tools we have […]

